Although HER2/Neu is not expressed in BLBCs, it is an important therapeutic target in other breast cancers (Arteaga et al, 2011; Hurvitz et al, 2013; Stern, 2012), and is itself a target of c-Cbl regulation (Levkowitz et al, 1996). Here, ERBB2 is linked to breast carcinoma.